You will be able to find all of our recent and archived news announcements. Our press releases are intended for business journalists and analysts/investors.
GSK to divest ofatumumab for auto-immune indications to Novartis for up to $1 billion plus royalties
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced an agreement with Novartis Pharma AG (“Novartis Pharma”), a subsidiary of Novartis AG, to divest its rights in ofatumumab for auto-immune indications, including multiple sclerosis.
GSK delivers Q2 Group sales of £5.9 billion +7% CER and core EPS of 17.3p (flat CER) in first full quarter of performance since transaction
GSK today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for the expansion of the SynflorixTM European label
GSK’s malaria candidate vaccine, Mosquirix™ (RTS,S), receives positive opinion from European regulators for the prevention of malaria in young children in sub-Saharan Africa
GSK announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive scientific opinion for its malaria candidate vaccine Mosquirix.
Explore more stories and features
Increasing access in India
We’ve embarked on a major initiative to ensure that our entire range of wellness, oral health, nutrition and food products are available even in the remotest villages.